Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.201
-0.009 (-4.29%)
At close: Apr 28, 2026, 4:00 PM EDT
0.207
+0.006 (2.99%)
Pre-market: Apr 29, 2026, 4:01 AM EDT
Sangamo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 83 | 141 | 213 | 96 | 515 | 1,093 | |
| Market Cap Growth | -48.47% | -33.59% | 120.88% | -81.28% | -52.90% | -50.50% | |
| Enterprise Value | 89 | 137 | 201 | -1 | 204 | 614 | |
| Last Close Price | 0.20 | 0.42 | 1.02 | 0.54 | 3.14 | 7.50 | |
| PS Ratio | 2.11 | 3.57 | 3.68 | 0.55 | 4.62 | 9.87 | |
| PB Ratio | - | -9.90 | 9.35 | 1.16 | 1.75 | 2.91 | |
| P/TBV Ratio | - | - | 9.35 | 1.16 | 2.49 | 3.88 | |
| EV/Sales Ratio | 2.25 | 3.47 | 3.48 | - | 1.83 | 5.54 | |
| Debt / Equity Ratio | -1.88 | -1.88 | 1.34 | 0.46 | 0.15 | 0.13 | |
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.50 | -0.52 | -0.90 | -1.11 | |
| Net Debt / EBITDA Ratio | -0.06 | -0.06 | 0.12 | 0.43 | 1.40 | 2.40 | |
| Net Debt / FCF Ratio | -0.06 | -0.06 | 0.17 | 0.17 | 1.08 | 1.62 | |
| Asset Turnover | 0.49 | 0.49 | 0.43 | 0.48 | 0.17 | 0.13 | |
| Quick Ratio | 0.74 | 0.74 | 1.02 | 1.78 | 2.53 | 2.99 | |
| Current Ratio | 0.84 | 0.84 | 1.13 | 1.98 | 2.69 | 3.12 | |
| Return on Equity (ROE) | -2891.84% | -2891.84% | -185.39% | -136.47% | -57.37% | -40.86% | |
| Return on Assets (ROA) | -83.66% | -83.66% | -46.00% | -19.63% | -19.59% | -13.80% | |
| Return on Capital Employed (ROCE) | -625.10% | -625.10% | -176.00% | -97.20% | -44.60% | -30.90% | |
| Earnings Yield | -147.63% | -86.98% | -46.02% | -267.59% | -37.37% | -16.32% | |
| FCF Yield | -116.86% | -68.85% | -31.67% | -255.31% | -47.38% | -23.48% | |
| Buyback Yield / Dilution | -38.92% | -38.92% | -15.62% | -13.02% | -6.76% | -7.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.